Boris Vishnevsky
About
In The Last Decade
Boris Vishnevsky
17 papers receiving 414 citations
Peers
Comparison fields: 5 of 28
- Infectious Diseases 413
- Epidemiology 390
- Surgery 271
- Molecular Biology 53
- Molecular Medicine 30
Countries citing papers authored by Boris Vishnevsky
This map shows the geographic impact of Boris Vishnevsky's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Boris Vishnevsky with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Boris Vishnevsky more than expected).
Fields of papers citing papers by Boris Vishnevsky
This network shows the impact of papers produced by Boris Vishnevsky. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Boris Vishnevsky. The network helps show where Boris Vishnevsky may publish in the future.
Co-authorship network of co-authors of Boris Vishnevsky
This figure shows the co-authorship network connecting the top 25 collaborators of Boris Vishnevsky. A scholar is included among the top collaborators of Boris Vishnevsky based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Boris Vishnevsky. Boris Vishnevsky is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 6 | |
| 3 | 4 | |
| 4 | 6 | |
| 5 | 31 | |
| 6 | 22 | |
| 7 | 30 | |
| 8 | 4 | |
| 9 | Certain surfactants significantly enhance the activity of antibiotics in the mouse model of MTB and drug resistant MTB infection and effectively remove the bacteria from a pulmonary cavity in human ex-vivo study. | 1 |
| 10 | 1 | |
| 11 | 4 | |
| 12 | 39 | |
| 13 | 48 | |
| 14 | 1 | |
| 15 | 65 | |
| 16 | 30 | |
| 17 | 63 | |
| 18 | 78 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.